Uganda National Examinations Board — Clinical library

Antibiotics & Antimicrobial Stewardship

Prescribing guidance, antibiograms, AMR in Uganda, ESBL/polymyxin guidance, duration of therapy and penicillin-allergy workarounds.

This collection provides resources on antibiotic prescribing and antimicrobial resistance, specifically tailored for clinicians in Uganda and East Africa. It includes guidelines, clinical notes, and reports that address common infections, resistance patterns, and stewardship practices.

01Guidelines & protocolsAntimicrobial Prescribing Guidance for Common InfectionsNICEInfectious Diseases· 2025· 31 pagesStart here — prescribing guidance for common infections
02Clinical notesANTIMICROBIAL REGIMEN SELECTIONKatie B.Infectious Diseases· 7 pagesRegimen selection
03Lecture slidesAntibiogram CMEKawempe National Referral HospitalInfectious Diseases· 2024· 15 pagesReading an antibiogram
04Clinical reviewsGlobal Antibiotic Resistance Surveillance Report 2025: SummaryWorld Health OrganizationInfectious Diseases· 2025· 20 pagesRead: Antibiotic resistance · pp. 13–14WHO global resistance report
05Clinical reviewsAntimicrobial resistance and antimicrobial stewardship a frontline (2)M. J. KreugerInternal Medicine· 2025· 11 pagesRead: pp. 8–9Stewardship frontline
06Clinical reviewsAntibiotic resistance in select RRHs in UgandaInfectious Diseases Institute, Makerere University College of Health Sciences; Ministry of Health; Regional Referral Hospital; Department of Microbiology, Mbarara University of Science and TechnologyInternal Medicine· 2024· 19 pagesRead: Discussion · p. 16Resistance in Ugandan RRHs
07Clinical reviewsANTIBIOTIC MYTHS FOR THE INFECTIOUS DISEASES CLINICIANUniversity of Pittsburgh School of Medicine; Duke University Medical Center; Temple UniversityInfectious Diseases· 2023· 13 pagesAntibiotic myths
08Clinical reviewsWHEN ORAL THERAPY CAN REPLACE INTRAVENOUS ANTIBIOTICS—CHANGING PRACTICE AS NEW DATA EMERGELos Angeles County and University of Southern California (LAC+USC) Medical CenterInfectious Diseases· 2023· 2 pagesWhen oral can replace IV
09Clinical reviewsDURATION OF ANTIBIOTIC THERAPY: WITH OR WITHOUT BIOMARKERS?Department of Critical Care Medicine, Hospital de São Francisco Xavier, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal; NOVA Medical School, Comprehensive Health Research Centre, NOVA University of Lisbon, Lisbon, Portugal; Center forCritical Care· 11 pagesDuration of therapy & biomarkers
10Guidelines & protocolsINFECTIOUS DISEASES SOCIETY OF AMERICA GUIDANCE ON THE TREATMENT OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ENTEROBACTERALES (ESBL-E), CARBAPENEM-RESISTANT ENTEROBACTERALES (CRE), AND PSEUDOMONAS AERUGINOSA WITH DIFFICULT-TO-TREAT RESISTANCE (DTR- P.Johns Hopkins University School of Medicine, The University of Texas MD Anderson Cancer Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, University Hospitals Cleveland Medical Center, University of Virginia, University ofInfectious Diseases· 8 pagesIDSA ESBL guidance
11Guidelines & protocolsINTERNATIONAL CONSENSUS GUIDELINES FOR THE OPTIMAL USE OF THE POLYMYXINSSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York; Detroit Medical Center; Department of Internal Medicine, Medical School, Universidade Federal do Rio Grande do Sul; Infectious Diseases Institute, RambamInfectious Diseases· 2019· 30 pagesPolymyxins consensus
12Clinical toolsAPPROACH TO THE PATIENT WITH A PAST PENICILLIN REACTION WHO REQUIRES ANTIBIOTICSMicrobiology & Immunology· 1 pagesPenicillin-allergy workarounds

Collection updated Sep 2026 · Access follows each resource's usual availability.

Open collection page →